UK markets close in 4 hours 59 minutes
  • FTSE 100

    7,888.24
    +51.53 (+0.66%)
     
  • FTSE 250

    20,340.13
    -69.25 (-0.34%)
     
  • AIM

    881.57
    -2.22 (-0.25%)
     
  • GBP/EUR

    1.1191
    -0.0015 (-0.14%)
     
  • GBP/USD

    1.1983
    -0.0041 (-0.34%)
     
  • BTC-GBP

    19,194.36
    +92.04 (+0.48%)
     
  • CMC Crypto 200

    528.70
    +3.57 (+0.68%)
     
  • S&P 500

    4,111.08
    -25.40 (-0.61%)
     
  • DOW

    33,891.02
    -34.99 (-0.10%)
     
  • CRUDE OIL

    75.47
    +1.36 (+1.84%)
     
  • GOLD FUTURES

    1,882.10
    +2.60 (+0.14%)
     
  • NIKKEI 225

    27,685.47
    -8.18 (-0.03%)
     
  • HANG SENG

    21,298.70
    +76.54 (+0.36%)
     
  • DAX

    15,326.32
    -19.59 (-0.13%)
     
  • CAC 40

    7,141.81
    +4.71 (+0.07%)
     

Global Prostate Cancer Diagnostics Market to Reach $8.8 Billion by 2027

ReportLinker
ReportLinker

In the changed post COVID-19 business landscape, the global market for Prostate Cancer Diagnostics estimated at US$3. 4 Billion in the year 2020, is projected to reach a revised size of US$8. 8 Billion by 2027, growing at aCAGR of 14.

New York, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Prostate Cancer Diagnostics Industry" - https://www.reportlinker.com/p06032688/?utm_source=GNW
7% over the period 2020-2027. Preliminary, one of the segments analyzed in the report, is projected to record 14% CAGR and reach US$6.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Confirmatory segment is readjusted to a revised 16.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $915.3 Million, While China is Forecast to Grow at 19% CAGR

The Prostate Cancer Diagnostics market in the U.S. is estimated at US$915.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2027 trailing a CAGR of 19% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.6% and 12.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 11.7% CAGR.

Select Competitors (Total 34 Featured) -
3D Signatures
Abbott
Beckman Coulter, Inc.
Biomérieux Sa
Diasorin S.P.A.
F. Hoffman La Roche Ltd.
Genomic Health
Mdxhealth
Myriad Genetic, Inc.
Opko Health, Inc.
Siemens Healthcare Gmbh


Read the full report: https://www.reportlinker.com/p06032688/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Prostate Cancer Diagnostics - Global Key Competitors Percentage
Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Prostate Cancer Diagnostics by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Prostate Cancer Diagnostics
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Prostate Cancer
Diagnostics by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2012, 2021 & 2027

Table 4: World Recent Past, Current & Future Analysis for
Preliminary by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Preliminary by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Preliminary by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for
Confirmatory by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Confirmatory by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Confirmatory by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 10: World Prostate Cancer Diagnostics Market Analysis of
Annual Sales in US$ Million for Years 2012 through 2027

III. MARKET ANALYSIS

UNITED STATES
Prostate Cancer Diagnostics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in the United States for 2022
(E)
Table 11: USA Recent Past, Current & Future Analysis for
Prostate Cancer Diagnostics by Test Type - Preliminary and
Confirmatory - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 12: USA Historic Review for Prostate Cancer Diagnostics
by Test Type - Preliminary and Confirmatory Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 13: USA 15-Year Perspective for Prostate Cancer
Diagnostics by Test Type - Percentage Breakdown of Value Sales
for Preliminary and Confirmatory for the Years 2012, 2021 &
2027

CANADA
Table 14: Canada Recent Past, Current & Future Analysis for
Prostate Cancer Diagnostics by Test Type - Preliminary and
Confirmatory - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 15: Canada Historic Review for Prostate Cancer
Diagnostics by Test Type - Preliminary and Confirmatory Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 16: Canada 15-Year Perspective for Prostate Cancer
Diagnostics by Test Type - Percentage Breakdown of Value Sales
for Preliminary and Confirmatory for the Years 2012, 2021 &
2027

JAPAN
Prostate Cancer Diagnostics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Japan for 2022 (E)
Table 17: Japan Recent Past, Current & Future Analysis for
Prostate Cancer Diagnostics by Test Type - Preliminary and
Confirmatory - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 18: Japan Historic Review for Prostate Cancer Diagnostics
by Test Type - Preliminary and Confirmatory Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 19: Japan 15-Year Perspective for Prostate Cancer
Diagnostics by Test Type - Percentage Breakdown of Value Sales
for Preliminary and Confirmatory for the Years 2012, 2021 &
2027

CHINA
Prostate Cancer Diagnostics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in China for 2022 (E)
Table 20: China Recent Past, Current & Future Analysis for
Prostate Cancer Diagnostics by Test Type - Preliminary and
Confirmatory - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 21: China Historic Review for Prostate Cancer Diagnostics
by Test Type - Preliminary and Confirmatory Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 22: China 15-Year Perspective for Prostate Cancer
Diagnostics by Test Type - Percentage Breakdown of Value Sales
for Preliminary and Confirmatory for the Years 2012, 2021 &
2027

EUROPE
Prostate Cancer Diagnostics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Europe for 2022 (E)
Table 23: Europe Recent Past, Current & Future Analysis for
Prostate Cancer Diagnostics by Geographic Region - France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 24: Europe Historic Review for Prostate Cancer
Diagnostics by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 25: Europe 15-Year Perspective for Prostate Cancer
Diagnostics by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK, Spain, Russia and
Rest of Europe Markets for Years 2012, 2021 & 2027

Table 26: Europe Recent Past, Current & Future Analysis for
Prostate Cancer Diagnostics by Test Type - Preliminary and
Confirmatory - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 27: Europe Historic Review for Prostate Cancer
Diagnostics by Test Type - Preliminary and Confirmatory Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 28: Europe 15-Year Perspective for Prostate Cancer
Diagnostics by Test Type - Percentage Breakdown of Value Sales
for Preliminary and Confirmatory for the Years 2012, 2021 &
2027

FRANCE
Prostate Cancer Diagnostics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in France for 2022 (E)
Table 29: France Recent Past, Current & Future Analysis for
Prostate Cancer Diagnostics by Test Type - Preliminary and
Confirmatory - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 30: France Historic Review for Prostate Cancer
Diagnostics by Test Type - Preliminary and Confirmatory Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 31: France 15-Year Perspective for Prostate Cancer
Diagnostics by Test Type - Percentage Breakdown of Value Sales
for Preliminary and Confirmatory for the Years 2012, 2021 &
2027

GERMANY
Prostate Cancer Diagnostics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Germany for 2022 (E)
Table 32: Germany Recent Past, Current & Future Analysis for
Prostate Cancer Diagnostics by Test Type - Preliminary and
Confirmatory - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 33: Germany Historic Review for Prostate Cancer
Diagnostics by Test Type - Preliminary and Confirmatory Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 34: Germany 15-Year Perspective for Prostate Cancer
Diagnostics by Test Type - Percentage Breakdown of Value Sales
for Preliminary and Confirmatory for the Years 2012, 2021 &
2027

ITALY
Table 35: Italy Recent Past, Current & Future Analysis for
Prostate Cancer Diagnostics by Test Type - Preliminary and
Confirmatory - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 36: Italy Historic Review for Prostate Cancer Diagnostics
by Test Type - Preliminary and Confirmatory Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 37: Italy 15-Year Perspective for Prostate Cancer
Diagnostics by Test Type - Percentage Breakdown of Value Sales
for Preliminary and Confirmatory for the Years 2012, 2021 &
2027

UNITED KINGDOM
Prostate Cancer Diagnostics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in the United Kingdom for 2022
(E)
Table 38: UK Recent Past, Current & Future Analysis for
Prostate Cancer Diagnostics by Test Type - Preliminary and
Confirmatory - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 39: UK Historic Review for Prostate Cancer Diagnostics by
Test Type - Preliminary and Confirmatory Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 40: UK 15-Year Perspective for Prostate Cancer
Diagnostics by Test Type - Percentage Breakdown of Value Sales
for Preliminary and Confirmatory for the Years 2012, 2021 &
2027

SPAIN
Table 41: Spain Recent Past, Current & Future Analysis for
Prostate Cancer Diagnostics by Test Type - Preliminary and
Confirmatory - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 42: Spain Historic Review for Prostate Cancer Diagnostics
by Test Type - Preliminary and Confirmatory Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 43: Spain 15-Year Perspective for Prostate Cancer
Diagnostics by Test Type - Percentage Breakdown of Value Sales
for Preliminary and Confirmatory for the Years 2012, 2021 &
2027

RUSSIA
Table 44: Russia Recent Past, Current & Future Analysis for
Prostate Cancer Diagnostics by Test Type - Preliminary and
Confirmatory - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 45: Russia Historic Review for Prostate Cancer
Diagnostics by Test Type - Preliminary and Confirmatory Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 46: Russia 15-Year Perspective for Prostate Cancer
Diagnostics by Test Type - Percentage Breakdown of Value Sales
for Preliminary and Confirmatory for the Years 2012, 2021 &
2027

REST OF EUROPE
Table 47: Rest of Europe Recent Past, Current & Future Analysis
for Prostate Cancer Diagnostics by Test Type - Preliminary and
Confirmatory - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 48: Rest of Europe Historic Review for Prostate Cancer
Diagnostics by Test Type - Preliminary and Confirmatory Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 49: Rest of Europe 15-Year Perspective for Prostate
Cancer Diagnostics by Test Type - Percentage Breakdown of Value
Sales for Preliminary and Confirmatory for the Years 2012, 2021 &
2027

ASIA-PACIFIC
Prostate Cancer Diagnostics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Table 50: Asia-Pacific Recent Past, Current & Future Analysis
for Prostate Cancer Diagnostics by Geographic Region -
Australia, India, South Korea and Rest of Asia-Pacific Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 51: Asia-Pacific Historic Review for Prostate Cancer
Diagnostics by Geographic Region - Australia, India, South
Korea and Rest of Asia-Pacific Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 52: Asia-Pacific 15-Year Perspective for Prostate Cancer
Diagnostics by Geographic Region - Percentage Breakdown of
Value Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2021 & 2027

Table 53: Asia-Pacific Recent Past, Current & Future Analysis
for Prostate Cancer Diagnostics by Test Type - Preliminary and
Confirmatory - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 54: Asia-Pacific Historic Review for Prostate Cancer
Diagnostics by Test Type - Preliminary and Confirmatory Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 55: Asia-Pacific 15-Year Perspective for Prostate Cancer
Diagnostics by Test Type - Percentage Breakdown of Value Sales
for Preliminary and Confirmatory for the Years 2012, 2021 &
2027

AUSTRALIA
Prostate Cancer Diagnostics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Australia for 2022 (E)
Table 56: Australia Recent Past, Current & Future Analysis for
Prostate Cancer Diagnostics by Test Type - Preliminary and
Confirmatory - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 57: Australia Historic Review for Prostate Cancer
Diagnostics by Test Type - Preliminary and Confirmatory Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 58: Australia 15-Year Perspective for Prostate Cancer
Diagnostics by Test Type - Percentage Breakdown of Value Sales
for Preliminary and Confirmatory for the Years 2012, 2021 &
2027

INDIA
Prostate Cancer Diagnostics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in India for 2022 (E)
Table 59: India Recent Past, Current & Future Analysis for
Prostate Cancer Diagnostics by Test Type - Preliminary and
Confirmatory - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 60: India Historic Review for Prostate Cancer Diagnostics
by Test Type - Preliminary and Confirmatory Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 61: India 15-Year Perspective for Prostate Cancer
Diagnostics by Test Type - Percentage Breakdown of Value Sales
for Preliminary and Confirmatory for the Years 2012, 2021 &
2027

SOUTH KOREA
Table 62: South Korea Recent Past, Current & Future Analysis
for Prostate Cancer Diagnostics by Test Type - Preliminary and
Confirmatory - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 63: South Korea Historic Review for Prostate Cancer
Diagnostics by Test Type - Preliminary and Confirmatory Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 64: South Korea 15-Year Perspective for Prostate Cancer
Diagnostics by Test Type - Percentage Breakdown of Value Sales
for Preliminary and Confirmatory for the Years 2012, 2021 &
2027

REST OF ASIA-PACIFIC
Table 65: Rest of Asia-Pacific Recent Past, Current & Future
Analysis for Prostate Cancer Diagnostics by Test Type -
Preliminary and Confirmatory - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 66: Rest of Asia-Pacific Historic Review for Prostate
Cancer Diagnostics by Test Type - Preliminary and Confirmatory
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 67: Rest of Asia-Pacific 15-Year Perspective for Prostate
Cancer Diagnostics by Test Type - Percentage Breakdown of Value
Sales for Preliminary and Confirmatory for the Years 2012, 2021 &
2027

LATIN AMERICA
Prostate Cancer Diagnostics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Latin America for 2022 (E)
Table 68: Latin America Recent Past, Current & Future Analysis
for Prostate Cancer Diagnostics by Geographic Region -
Argentina, Brazil, Mexico and Rest of Latin America Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 69: Latin America Historic Review for Prostate Cancer
Diagnostics by Geographic Region - Argentina, Brazil, Mexico
and Rest of Latin America Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 70: Latin America 15-Year Perspective for Prostate Cancer
Diagnostics by Geographic Region - Percentage Breakdown of
Value Sales for Argentina, Brazil, Mexico and Rest of Latin
America Markets for Years 2012, 2021 & 2027

Table 71: Latin America Recent Past, Current & Future Analysis
for Prostate Cancer Diagnostics by Test Type - Preliminary and
Confirmatory - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 72: Latin America Historic Review for Prostate Cancer
Diagnostics by Test Type - Preliminary and Confirmatory Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 73: Latin America 15-Year Perspective for Prostate Cancer
Diagnostics by Test Type - Percentage Breakdown of Value Sales
for Preliminary and Confirmatory for the Years 2012, 2021 &
2027

ARGENTINA
Table 74: Argentina Recent Past, Current & Future Analysis for
Prostate Cancer Diagnostics by Test Type - Preliminary and
Confirmatory - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 75: Argentina Historic Review for Prostate Cancer
Diagnostics by Test Type - Preliminary and Confirmatory Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 76: Argentina 15-Year Perspective for Prostate Cancer
Diagnostics by Test Type - Percentage Breakdown of Value Sales
for Preliminary and Confirmatory for the Years 2012, 2021 &
2027

BRAZIL
Table 77: Brazil Recent Past, Current & Future Analysis for
Prostate Cancer Diagnostics by Test Type - Preliminary and
Confirmatory - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 78: Brazil Historic Review for Prostate Cancer
Diagnostics by Test Type - Preliminary and Confirmatory Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 79: Brazil 15-Year Perspective for Prostate Cancer
Diagnostics by Test Type - Percentage Breakdown of Value Sales
for Preliminary and Confirmatory for the Years 2012, 2021 &
2027

MEXICO
Table 80: Mexico Recent Past, Current & Future Analysis for
Prostate Cancer Diagnostics by Test Type - Preliminary and
Confirmatory - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 81: Mexico Historic Review for Prostate Cancer
Diagnostics by Test Type - Preliminary and Confirmatory Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 82: Mexico 15-Year Perspective for Prostate Cancer
Diagnostics by Test Type - Percentage Breakdown of Value Sales
for Preliminary and Confirmatory for the Years 2012, 2021 &
2027

REST OF LATIN AMERICA
Table 83: Rest of Latin America Recent Past, Current & Future
Analysis for Prostate Cancer Diagnostics by Test Type -
Preliminary and Confirmatory - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 84: Rest of Latin America Historic Review for Prostate
Cancer Diagnostics by Test Type - Preliminary and Confirmatory
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 85: Rest of Latin America 15-Year Perspective for
Prostate Cancer Diagnostics by Test Type - Percentage Breakdown
of Value Sales for Preliminary and Confirmatory for the Years
2012, 2021 & 2027

MIDDLE EAST
Prostate Cancer Diagnostics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Middle East for 2022 (E)
Table 86: Middle East Recent Past, Current & Future Analysis
for Prostate Cancer Diagnostics by Geographic Region - Iran,
Israel, Saudi Arabia, UAE and Rest of Middle East Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 87: Middle East Historic Review for Prostate Cancer
Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia,
UAE and Rest of Middle East Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 88: Middle East 15-Year Perspective for Prostate Cancer
Diagnostics by Geographic Region - Percentage Breakdown of
Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of
Middle East Markets for Years 2012, 2021 & 2027

Table 89: Middle East Recent Past, Current & Future Analysis
for Prostate Cancer Diagnostics by Test Type - Preliminary and
Confirmatory - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 90: Middle East Historic Review for Prostate Cancer
Diagnostics by Test Type - Preliminary and Confirmatory Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 91: Middle East 15-Year Perspective for Prostate Cancer
Diagnostics by Test Type - Percentage Breakdown of Value Sales
for Preliminary and Confirmatory for the Years 2012, 2021 &
2027

IRAN
Table 92: Iran Recent Past, Current & Future Analysis for
Prostate Cancer Diagnostics by Test Type - Preliminary and
Confirmatory - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 93: Iran Historic Review for Prostate Cancer Diagnostics
by Test Type - Preliminary and Confirmatory Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 94: Iran 15-Year Perspective for Prostate Cancer
Diagnostics by Test Type - Percentage Breakdown of Value Sales
for Preliminary and Confirmatory for the Years 2012, 2021 &
2027

ISRAEL
Table 95: Israel Recent Past, Current & Future Analysis for
Prostate Cancer Diagnostics by Test Type - Preliminary and
Confirmatory - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 96: Israel Historic Review for Prostate Cancer
Diagnostics by Test Type - Preliminary and Confirmatory Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 97: Israel 15-Year Perspective for Prostate Cancer
Diagnostics by Test Type - Percentage Breakdown of Value Sales
for Preliminary and Confirmatory for the Years 2012, 2021 &
2027

SAUDI ARABIA
Table 98: Saudi Arabia Recent Past, Current & Future Analysis
for Prostate Cancer Diagnostics by Test Type - Preliminary and
Confirmatory - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 99: Saudi Arabia Historic Review for Prostate Cancer
Diagnostics by Test Type - Preliminary and Confirmatory Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 100: Saudi Arabia 15-Year Perspective for Prostate Cancer
Diagnostics by Test Type - Percentage Breakdown of Value Sales
for Preliminary and Confirmatory for the Years 2012, 2021 &
2027

UNITED ARAB EMIRATES
Table 101: UAE Recent Past, Current & Future Analysis for
Prostate Cancer Diagnostics by Test Type - Preliminary and
Confirmatory - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 102: UAE Historic Review for Prostate Cancer Diagnostics
by Test Type - Preliminary and Confirmatory Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 103: UAE 15-Year Perspective for Prostate Cancer
Diagnostics by Test Type - Percentage Breakdown of Value Sales
for Preliminary and Confirmatory for the Years 2012, 2021 &
2027

REST OF MIDDLE EAST
Table 104: Rest of Middle East Recent Past, Current & Future
Analysis for Prostate Cancer Diagnostics by Test Type -
Preliminary and Confirmatory - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 105: Rest of Middle East Historic Review for Prostate
Cancer Diagnostics by Test Type - Preliminary and Confirmatory
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 106: Rest of Middle East 15-Year Perspective for Prostate
Cancer Diagnostics by Test Type - Percentage Breakdown of Value
Sales for Preliminary and Confirmatory for the Years 2012, 2021 &
2027

AFRICA
Prostate Cancer Diagnostics Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Africa for 2022 (E)
Table 107: Africa Recent Past, Current & Future Analysis for
Prostate Cancer Diagnostics by Test Type - Preliminary and
Confirmatory - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 108: Africa Historic Review for Prostate Cancer
Diagnostics by Test Type - Preliminary and Confirmatory Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 109: Africa 15-Year Perspective for Prostate Cancer
Diagnostics by Test Type - Percentage Breakdown of Value Sales
for Preliminary and Confirmatory for the Years 2012, 2021 &
2027

IV. COMPETITION
Read the full report: https://www.reportlinker.com/p06032688/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001